Zelira Therapeutics Ltd (ZLD) — Capital Reinvestment Ratio

Latest as of December 2015: 0.23x

Zelira Therapeutics Ltd (ZLD) has a Capital Reinvestment Ratio of 0.23x as of December 2015, meaning it reinvests 0% of its operating cash flow (AU$159.61K) in capital expenditures (AU$36.80K). See ZLD net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.23x
Capex / Operating Cash Flow

Operating Cash Flow

AU$159.61K
AUD

Capital Expenditures

AU$36.80K
AUD

Data as of

Dec 2015
Most recent filing

Zelira Therapeutics Ltd Capital Reinvestment Ratio (2011–2011)

This chart tracks Zelira Therapeutics Ltd's Capital Reinvestment Ratio across 1 annual periods. Check total reinvestment intensity of Zelira Therapeutics Ltd to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Zelira Therapeutics Ltd (2011–2011)

Year-by-year Capital Reinvestment Ratio for Zelira Therapeutics Ltd from 2011 to 2011. For live market cap and broader valuation context, see ZLD market cap.

Year Reinvestment Ratio Operating CF (AUD) Capital Expenditures YoY Change
2011 0.14x AU$101.92K AU$13.95K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow